|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 43.52 USD | -1.96% |
|
+1.37% | -44.99% |
| 22/10 | Wall Street, Please Make Up Your Mind on AI |  |
| 22/10 | BMO Capital Upgrades Ionis Pharmaceuticals to Outperform From Market Perform | MT |
| Market Cap | 737.69Cr 660.68Cr 607.72Cr 550.64Cr 1.03TCr 70TCr 1.05TCr 7.25TCr 2.91TCr 37TCr 2.77TCr 2.71TCr 1,16200Cr | P/E 2026 * |
-12.5x | P/E 2027 * | -22.7x |
|---|---|---|---|---|---|
| Enterprise Value | 727.39Cr 651.45Cr 599.23Cr 542.96Cr 1.01TCr 69TCr 1.03TCr 7.15TCr 2.87TCr 36TCr 2.73TCr 2.67TCr 1,14600Cr | EV / Sales 2026 * |
7.89x | EV / Sales 2027 * | 5.47x |
| Free-Float |
99.06% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IONS | Delayed | |
CBOE
| IONS | Real-time | |
|
Tradegate
| ISI | Real-time | |
|
Mexican S.E.
| IONS * | End-of-day quote | |
|
Boerse Muenchen
| ISI | Real-time | |
|
Deutsche Boerse AG
| ISI | Delayed | |
|
Börse Stuttgart
| ISI | Delayed | |
|
Borsa Italiana
| 1IONS | End-of-day quote | |
|
Xetra
| ISI | Delayed |
Last Transcript: Ionis Pharmaceuticals, Inc.
| 1 day | -1.96% | ||
| 1 week | +1.37% | ||
| Current month | -2.53% | ||
| 1 month | -2.53% | ||
| 3 months | -18.32% | ||
| 6 months | -41.79% | ||
| Current year | -44.99% |
| 1 week | 42.76 |  | 45.84 |
| 1 month | 42.08 | | 45.95 |
| Current year | 42.08 | | 86.74 |
| 1 year | 42.08 | | 86.74 |
| 3 years | 23.95 | | 86.74 |
| 5 years | 23.95 | | 86.74 |
| 10 years | 23.95 | | 86.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
D. Walke
IRC | Investor Relations Contact | 60 | 01/07/2012 |
Brett Monia
CEO | Chief Executive Officer | 64 | 01/01/2020 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 64 | 01/05/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Klein
BRD | Director/Board Member | 64 | 13/12/2005 |
| Director/Board Member | 73 | 01/05/2002 | |
Brett Monia
BRD | Director/Board Member | 64 | 25/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Others | Chief Technology Officer | 110 | 0.0001% | ||
| 31/08/26 | Others | Executive/Senior Manager | 58 | 0.0000% | ||
| 31/08/26 | Others | Founder | 98 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.96% | +1.37% | -41.32% | -1.09% | 737.69Cr | |
| -0.62% | +0.50% | +33.92% | +60.07% | 6.44TCr | |
| +0.35% | +3.04% | +12.64% | +83.62% | 5.62TCr | |
| +0.53% | +2.55% | +13.90% | +104.77% | 5.42TCr | |
| -2.81% | -4.31% | +23.50% | +50.90% | 4.53TCr | |
| -0.33% | -1.93% | +20.15% | +98.45% | 4.22TCr | |
| +0.55% | +2.31% | +224.97% | +942.56% | 4.08TCr | |
| +3.27% | +47.40% | +110.44% | +94.92% | 3.38TCr | |
| +1.22% | -1.39% | +13.92% | +46.95% | 3.22TCr | |
| -1.29% | -1.72% | +21.00% | -6.85% | 2.36TCr | |
| Average | -0.12% | +4.36% | +43.31% | +147.43% | 4TCr | |
| Weighted average by Cap. | -0.03% | +3.59% | +47.77% | +159.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 92Cr 83Cr 76Cr 69Cr 128.7Cr 8.76TCr 131.11Cr 906.15Cr 363.76Cr 4.61TCr 346.16Cr 338.8Cr 15TCr | 135.99Cr 121.79Cr 112.03Cr 101.51Cr 189.75Cr 13TCr 193.3Cr 1.34TCr 536.31Cr 6.79TCr 510.36Cr 499.51Cr 21TCr |
| Net income | -58Cr -52Cr -48Cr -43Cr -81Cr -5.5TCr -82Cr -569.16Cr -228.48Cr -2.89TCr -217.43Cr -212.8Cr -9.13TCr | -33Cr -29Cr -27Cr -24Cr -46Cr -3.11TCr -47Cr -321.59Cr -129.1Cr -1.63TCr -122.85Cr -120.24Cr -5.16TCr |
| Net Debt | -10Cr -9.22Cr -8.48Cr -7.69Cr -14Cr -977.89Cr -15Cr -101.18Cr -41Cr -514.4Cr -39Cr -38Cr -1.62TCr | 6.83Cr 6.12Cr 5.63Cr 5.1Cr 9.53Cr 648.59Cr 9.71Cr 67Cr 27Cr 341.17Cr 26Cr 25Cr 1.08TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | $43.52 | -1.96% | 15,21,572 |
| 29/26/29 | $44.39 | -1.14% | 18,33,848 |
| 28/26/28 | $44.90 | +2.14% | 17,24,370 |
| 27/26/27 | $43.96 | +1.24% | 23,76,841 |
| 26/26/26 | $43.42 | +1.14% | 31,97,537 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IONS Stock
Select your edition
All financial news and data tailored to specific country editions
